Clinical trial
Efficacy of Olanzapine on Weight Gain in Women with Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial
NCT06288854 is registered in ClinicalTrials.gov with Department of Medical Services Ministry of Public Health of Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Olanzapine on Weight Gain in Women with Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial
- Lead sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 3, 2024
- Completion date
- June 30, 2025
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.